[Biological therapy in rheumatoid arthritis]

Area of Science:

• Immunology
• Rheumatology
• Pharmacology

Context:

• Rheumatoid arthritis (RA) is a prevalent autoimmune disease with significant public health implications.
• Current treatments, like cytotoxic drugs, are ineffective for a substantial portion of RA patients.
• Biotechnology has introduced biological therapies as a novel treatment avenue for RA.

Purpose:

• To review the multifaceted aspects of biological therapy in rheumatoid arthritis.
• To present preliminary findings from clinical trials evaluating biological therapies in RA patients.

Summary:

• Biological therapy represents a significant advancement in managing rheumatoid arthritis.
• This therapeutic approach targets specific immune pathways involved in RA pathogenesis.
• Initial clinical trial data suggest promising outcomes for biological therapies in RA treatment.

Impact:

• Biological therapies offer new hope for RA patients with inadequate responses to conventional treatments.
• This review provides valuable insights for clinicians and researchers in the field of rheumatology.
• Advances in biotechnology are transforming the landscape of autoimmune disease management.